You are here
Home 🌿 Medical Cannabis News 🌿 Study To Assess CBD And CBN’s Potential For Better Sleep 🌿Study To Assess CBD And CBN’s Potential For Better Sleep
Warning message
The subscription service is currently unavailable. Please try again later.Charlotte’s Web Holdings is teaming up with the University of Colorado-Boulder on investigating supporting improved sleep with two cannabinoids.
Many people would be familiar with the cannabinoid CBD (cannabidiol) these days, but it’s just one of many cannabinoids in cannabis. Another is CBN – cannabinol, which is found only in trace amounts in the plant.
Charlotte’s Web says while there is some anecdotal evidence for CBN supporting better sleep, there is little substantiated clinical or preclinical evidence to back these claims.
Charlotte’s Web’s CW Labs division is collaborating with University of Colorado-Boulder’s REACH (Research and Education Addressing Cannabis and Health) Center to investigate the company’s full spectrum hemp formulations with CBN (cannabinol) and CBD (cannabidiol) to examine the impact on anxiety and sleep quality. These formulations contain less than 0.3% THC.
University of Colorado-Boulder’s Monika Fleshner, PhD, Professor of Integrative Physiology, and a member of the Center for Neuroscience at the University is lead for the project, which will be conducted her Stress Physiology Laboratory.
“With support from CU REACH and Charlotte’s Web, our research will explore both the efficacy and mechanisms of how these substances can affect complex brain-mediated behavior, such as disturbed sleep,” said Professor Fleshner.
Charlotte’s Web is a well known CBD brand in the USA, but in case you’re not familiar with it, you may be wondering about the name.
Back in 2011, Stanley Brothers developed proprietary hemp genetics that would become the basis of their products. In 2012, Paige Figi was looking for non-intoxicating products to treat her 5 year old daughter Charlotte, who suffered from seizures accompanying Dravet’s Syndrome, a severe form of epilepsy. The seizures reportedly reduced from her first dose and ultimately reduced from 300 a week – even with other medications – down to two or three a week.
Charlotte’s situation was put in the spotlight after CNN’s chief medical correspondent Dr. Sanjay Gupta met with the family – it was among the triggers for Dr. Gupta changing his stance on medical cannabis.
And the rest is history.
Unfortunately, Charlotte passed away last year, aged 13.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.